Physician profile
Gary Gruber
NPI 1558305060
$2,142.95
in general payments reported to CMS, 2019-2025
23 companies · $155 in 2025
The $155 reported for 2025 was more than what 84% of Chiropractor providers received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $107 · 2021: $529 · 2022: $404 · 2023: $424 · 2024: $338 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $606.89 | 2019-2025 | |
| Novo Nordisk INC | $319.99 | 2019-2025 | Rybelsus, Wegovy, Ozempic |
| Abbott Laboratories | $218.52 | 2019-2024 | Freestyle Libre 3, Proclaim, Eterna |
| Medtronic, INC. | $118.78 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Amgen INC. | $107.50 | 2021-2024 | Otezla, Repatha |
| Boston Scientific Corporation | $97.11 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nestle Healthcare Nutrition INC. | $94.77 | 2021-2022 | |
| Vivus LLC | $93.79 | 2021-2024 | Qsymia |
| Otsuka America Pharmaceutical, INC. | $82.25 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.62 | 2021-2024 | Jardiance |
| Lilly USA, LLC | $55.90 | 2021-2022 | |
| Eisai INC. | $51.38 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $42.49 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $32.69 | 2023-2024 | Nuzyra |
| Sonex Health, INC. | $23.76 | 2023 | Sx-One Microknife |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $23.70 | 2025 | Neffy |
| Tms Neurohealth Centers INC. | $19.39 | 2025 | Tms Neurohealth Centers INC. |
| Biohaven Pharmaceuticals, INC. | $18.06 | 2021 | |
| Jazz Pharmaceuticals INC. | $16.81 | 2021 | |
| Inspire Medical Systems, INC. | $16.14 | 2023 | Inspire |
| Pfizer INC. | $14.35 | 2019 | |
| Merck Sharp & Dohme LLC | $13.55 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Gruber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.